Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
manufacturing of reference substances and purification processes based on patented HAPIpur® technology to automate continuous counter current crystallization.
Chemical
covering the complete API value-creation chain. Additionally
HAPILA can provide independent development and scale up of chemical API synthesis including analytical method development
Health Care
purification and particle design
HAPILA’s specializes in synthesis
Date founded
2007
Funding rounds raised
H
HAPILA GmbH raised undisclosed on September 23, 2008
Investors: High-Tech Gründerfonds